comparemela.com

Latest Breaking News On - Pediatr endocrinol - Page 2 : comparemela.com

Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted

GENEVA, Switzerland and NEWTON, Mass., Aug. 12, 2022 (GLOBE NEWSWIRE) RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief), and its collaboration partner, Acer Therapeutics Inc. (Nasdaq: ACER)

Adhoc: Relief Therapeutics Holding SA: Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease

Relief Therapeutics Holding SA / Key word(s): Regulatory Admission Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease 28-Jul-2022

Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease

28.07.2022 Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease | Relief Therapeutics Holding SA | News | Nachricht | Mitteilung

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.